Franklin Street Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-952
Closed -$121K 179
2016
Q4
$121K Hold
952
0.02% 164
2016
Q3
$146K Hold
952
0.03% 171
2016
Q2
$110K Hold
952
0.02% 192
2016
Q1
$108K Buy
952
+476
+100% +$54K 0.02% 215
2015
Q4
$90K Buy
476
+238
+100% +$45K 0.02% 217
2015
Q3
$41K Buy
+238
New +$41K 0.01% 223